首页> 外文OA文献 >Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report

【2h】

Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report

机译：Sacituzumab Govitecan（Immu-132）在治疗抗性子宫浆液癌中：案例报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chanhee Han; Stefania Bellone; Peter E. Schwartz; Serengulam V. Govindan; Robert M. Sharkey; David M. Goldenberg; Alessandro D. Santin;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report [J] . Chanhee Han, Stefania Bellone, Peter E. Schwartz, Gynecologic Oncology Reports . 2018,第2期

机译：Sacituzumab Govitecan（IMMU-132）治疗难治性子宫浆液性癌1例
2. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma [J] . Gynecologic Oncology: An International Journal . 2020,第2期

机译：在体外和体内活性的Sacituzumab Govitecan，靶向滋养细胞表面抗原2（Troph-2）的抗体 - 药物缀合物在子宫浆液癌中
3. Human epidermal growth factor receptor 2 (Her2) testing for uterine serous carcinoma: Report of scenarios of unusual overexpression [J] . M. Ruhul Quddus, Katrine Hansen, Umadevi Tantravahi, Gynecologic Oncology Reports . 2020,第2期

机译：人体表皮生长因子受体2（HER2）对子宫浆液癌的测试：异常过度表达的情况的报告
4. Global proteomic analysis of ovarian high-grade serous carcinomas using SWATH-MS for targeted verification of proteome changes associated with genomic alterations [C] . Stefani N. Thomas, Jing Chen, Paul Aiyetan, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：卵巢高级浆液癌的全局蛋白质组学分析使用SWATH-MS进行靶向验证与基因组改变相关的蛋白质组变化
5. Functional Characterization and Modeling of Factors Involved in High Grade Serous Ovarian Carcinoma Initiation [D] . Yamulla, Robert Joseph. 2020

机译：高级浆液癌癌癌中涉及的功能表征及造型
6. Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report [O] . Chanhee Han, Stefania Bellone, Peter E. Schwartz, 2018

机译：Sacituzumab Govitecan（IMMU-132）治疗难治性子宫浆液性癌1例
7. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases [O] . Bingjian Lu, Qin Chen, Xiaofei Zhang, 2016

机译：子宫残端子宫腺肌病/子宫腺肌病囊肿引起的浆液性癌3例报告
8. Pathogenesis of Ovarian Serous Carcinoma as the Basis for Immunologic Directed Diagnosis and Treatment. Project 2 - Identification of Autologous Antigens in Early Stage Serous Carcinoma [R] . Kurman, R. J. , Roden, R. 2003

机译：卵巢浆液性癌的发病机制是免疫定向诊断和治疗的基础。项目2 - 早期浆液性癌中自体抗原的鉴定

Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report

著录项

引文网络

相似文献

相关主题

期刊订阅